If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Get Updates
753
Followers on Owler
Beam
Therapeutics develops precision medicines through base editing technology to treat genetic diseases...
Read more
Overview
Competitors
Acquisitions
Funding
Investments
News & Insights
Beam
Therapeutics develops precision medicines through base editing technology to treat genetic diseases...
Read more
CEO
John Evans
CEO Approval Rating
90/100
Weigh In
2017
Cambridge
Massachusetts
Greater Boston
Public
NASDAQ
BEAM
Pharmaceuticals & Biotechnology
Biotechnology
2836
NAICS listing
https://beamtx.com/
Annual Revenue
$63.5M
Employees
510
Funding
$806.5M
Acquisitions
1
Investments
1
News
Key Events
Latest News
Conference Presentation
Mar 11, 2025
Nasdaq
Beam Therapeutics To Present At Barclays Global Healthcare Conference; Webcast At 3:30 PM ET
Follow and Get Alerts
Beam Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 20 + competitors
Trending Companies
